Liu Zeye, Huang Yuan, Yang Yang, Li Wenchao, Ju Wenhao, Zhang Fengwen, Ouyang Wenbin, Wang Shouzheng, Wang Cheng, An Xuanqi, Xia Ruibing, Li Yakun, Pan Xiangbin
Department of Structural Heart Disease, National Center for Cardiovascular Disease, China & Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, China.
National Health Commission Key Laboratory of Cardiovascular Regeneration Medicine, Beijing 100037, China.
J Transl Int Med. 2024 Jul 27;12(3):263-273. doi: 10.2478/jtim-2023-0117. eCollection 2024 Jun.
Comprehensive data analyses in heart failure research can provide academics with information and help policymakers formulate relevant policies. We collected data from reports published between 1945 and 2021 to identify research topics, trends, and cross-domains in the heart failure disease literature.
Text fragments were extracted and clustered from the titles and abstracts in 270617 publications using artificial intelligence techniques. Two algorithms were used to corroborate the results and ensure that they were reliable. Experts named themes and document clusters based on the results of these semiautomated methods. Using consistent methods, we identified and flagged 107 heart failure topics and 16 large document clusters (divided into two groups by time). The annual vocabularies of research hotspots were calculated to draw attention to niche research fields.
Clinical research is an expanding field, followed by basic research and population research. The most frequently raised issues were intensive care treatment for heart failure, applications of artificial intelligence technologies, cardiac assist devices, stem cells, genetics, and regional distribution and use of heart failure-related health care. Risk scoring and classification, care for patients, readmission, health economics of treatment and care, and cell regeneration and signaling pathways were among the fastest-growing themes. Drugs, signaling pathways, and biomarkers were all crucial issues for clinical and basic research in the entire population. Studies on intelligent medicine and telemedicine, interventional therapy for valvular disease, and novel coronavirus have emerged recently.
Clinical and population research is increasingly focusing on the customization of intelligent treatments, improving the quality of patients' life, and developing novel treatments. Basic research is increasingly focusing on regenerative medicine, translational medicine, and signaling pathways. Additionally, each research field exhibits mutual fusion characteristics. Medical demands, new technologies, and social support are all potential drivers for these changes.
心力衰竭研究中的综合数据分析可为学术界提供信息,并帮助政策制定者制定相关政策。我们收集了1945年至2021年间发表的报告中的数据,以确定心力衰竭疾病文献中的研究主题、趋势和跨领域情况。
使用人工智能技术从270617篇出版物的标题和摘要中提取文本片段并进行聚类。使用两种算法来证实结果并确保其可靠性。专家根据这些半自动方法的结果为主题和文档集群命名。我们采用一致的方法,识别并标记了107个心力衰竭主题和16个大型文档集群(按时间分为两组)。计算研究热点的年度词汇,以引起对小众研究领域的关注。
临床研究是一个不断扩展的领域,其次是基础研究和人群研究。最常提出的问题是心力衰竭的重症监护治疗、人工智能技术的应用、心脏辅助装置、干细胞、遗传学以及心力衰竭相关医疗保健的区域分布和使用。风险评分与分类、患者护理、再入院、治疗与护理的卫生经济学以及细胞再生和信号通路是增长最快的主题之一。药物、信号通路和生物标志物在整个人群的临床和基础研究中都是关键问题。智能医学和远程医学、瓣膜疾病的介入治疗以及新型冠状病毒的研究是最近出现的。
临床和人群研究越来越关注智能治疗的定制、提高患者生活质量以及开发新的治疗方法。基础研究越来越关注再生医学、转化医学和信号通路。此外,每个研究领域都呈现出相互融合的特征。医疗需求、新技术和社会支持都是这些变化的潜在驱动因素。